Michael Szelke

1.7k total citations
62 papers, 1.3k citations indexed

About

Michael Szelke is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Michael Szelke has authored 62 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 15 papers in Cardiology and Cardiovascular Medicine and 11 papers in Oncology. Recurrent topics in Michael Szelke's work include Chemical Synthesis and Analysis (15 papers), Renin-Angiotensin System Studies (15 papers) and Neuropeptides and Animal Physiology (10 papers). Michael Szelke is often cited by papers focused on Chemical Synthesis and Analysis (15 papers), Renin-Angiotensin System Studies (15 papers) and Neuropeptides and Animal Physiology (10 papers). Michael Szelke collaborates with scholars based in United Kingdom, Switzerland and United States. Michael Szelke's co-authors include Butrus Atrash, B Leckie, Dylan M. Jones, A. Hallett, Anthony F. Lever, D. Michael Jones, J.B. Cooper, J.E. Sueiras, T.L. Blundell and Hamish Ryder and has published in prestigious journals such as Nature, Gastroenterology and Journal of Molecular Biology.

In The Last Decade

Michael Szelke

61 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Szelke United Kingdom	20	764	237	230	226	218	62	1.3k
Jay R. Luly United States	24	947 1.2×	684 2.9×	91 0.4×	167 0.7×	231 1.1×	54	1.8k
Seymour Mong United States	27	974 1.3×	304 1.3×	140 0.6×	96 0.4×	306 1.4×	71	2.0k
J. PLUSCEC United States	12	732 1.0×	186 0.8×	248 1.1×	129 0.6×	137 0.6×	19	1.1k
Jon Read United Kingdom	25	1.3k 1.7×	369 1.6×	131 0.6×	61 0.3×	199 0.9×	40	2.1k
B. Kamber Switzerland	25	1.7k 2.2×	592 2.5×	344 1.5×	761 3.4×	177 0.8×	50	2.3k
Nigel J. Liverton United States	24	726 1.0×	711 3.0×	212 0.9×	128 0.6×	201 0.9×	61	1.8k
Alan D. Cardin United States	20	530 0.7×	86 0.4×	51 0.2×	105 0.5×	79 0.4×	48	1.3k
Frederic E. Dorer United States	20	893 1.2×	49 0.2×	203 0.9×	501 2.2×	224 1.0×	35	1.4k
Jonathan S. Rosenblum United States	19	1.3k 1.7×	138 0.6×	194 0.8×	40 0.2×	392 1.8×	32	1.8k
Herman H. Stein United States	20	652 0.9×	548 2.3×	82 0.4×	264 1.2×	105 0.5×	59	1.3k

Countries citing papers authored by Michael Szelke

Since Specialization

Citations

This map shows the geographic impact of Michael Szelke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Szelke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Szelke more than expected).

Fields of papers citing papers by Michael Szelke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Szelke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Szelke. The network helps show where Michael Szelke may publish in the future.

Co-authorship network of co-authors of Michael Szelke

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Szelke. A scholar is included among the top collaborators of Michael Szelke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Szelke. Michael Szelke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Szelke, Michael, et al.. (1997). Synthesis and biological activity of potent, low molecular weight renin inhibitors*. Journal of Peptide Research. 50(4). 248–261. 8 indexed citations

Szelke, Michael, et al.. (1997). New renin inhibitors containing novel analogues of statine. Journal of Peptide Research. 50(2). 109–121. 10 indexed citations

Szelke, Michael, et al.. (1997). Potent in vivo inhibitors of rat renin: Analogues of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site*. Journal of Peptide Research. 50(4). 239–247. 8 indexed citations

Featherstone, Roland L., Declan Evans, Dylan M. Jones, et al.. (1996). Mechanism of irritant-induced cough: Studies with a kinin antagonist and a kallikrein inhibitor. Lung. 174(4). 269–75. 16 indexed citations

Evans, Declan, D. Michael Jones, Doreen M. Ashworth, et al.. (1996). Synthetic inhibitors of human tissue kallikrein. Immunopharmacology. 32(1-3). 117–118. 16 indexed citations

Jones, D. Michael, et al.. (1995). Thrombin Inhibitors Based on Ketone Derivatives of Arginine and Lysine. Journal of enzyme inhibition. 9(1). 43–60. 10 indexed citations

Dealwis, Chris, Carlos Frazão, M. Badasso, et al.. (1994). X-ray Analysis at 2·0 Å Resolution of Mouse Submaxillary Renin Complexed with a Decapeptide Inhibitor CH-66, Based on the 4-16 Fragment of Rat Angiotensinogen. Journal of Molecular Biology. 236(1). 342–360. 34 indexed citations

Jones, D. Michael, et al.. (1993). A short stereocontrolled synthesis of hydroxyethylene dipeptide isosteres. The Journal of Organic Chemistry. 58(8). 2286–2290. 16 indexed citations

Webb, David J., Per Manhem, B Leckie, et al.. (1989). Severe hypotension with bradycardia during renin inhibition with H142 in sodium deplete man.. PubMed. 3(4). 227–32. 2 indexed citations

10.

Beattie, Elisabeth, James J. Morton, B Leckie, et al.. (1989). Inhibitors of rat renin and their use in experimental hypertension. Journal of Hypertension. 7(6). S220–221. 1 indexed citations

11.

Jones, Samuel E., Katarzyna M. Dzięgielewska, Norman R. Saunders, et al.. (1988). Early cortical plate specific glycoprotein in a marsupial species belongs to the same family as fetuin and α₂HS glycoprotein. FEBS Letters. 236(2). 411–414. 14 indexed citations

12.

Blundell, T.L., J.B. Cooper, S. Foundling, et al.. (1987). On the rational design of renin inhibitors: x-ray studies of aspartic proteinases complexed with transition-state analogs. Biochemistry. 26(18). 5585–5590. 82 indexed citations

13.

Foundling, S. I., J.B. Cooper, Laurence H. Pearl, et al.. (1987). Crystallographic Studies of Reduced Bond Inhibitors Complexed with an Aspartic Proteinase. Journal of Cardiovascular Pharmacology. 10. 59–68. 5 indexed citations

14.

Webb, David J., Per Manhem, Stephen G. Ball, et al.. (1987). Clinical and Biochemical Effects of the Renin Inhibitor H142 in Humans. Journal of Cardiovascular Pharmacology. 10. 69–74. 5 indexed citations

15.

Tree, M., Michael Szelke, B Leckie, et al.. (1985). Renin inhibitors: their use in understanding the role of angiotensin II as a pressor hormone.. PubMed. 7 Suppl 4. S49–52. 4 indexed citations

16.

Webb, David J., Per Manhem, Stephen G. Ball, et al.. (1985). A Study of the Renin Inhibitor H142 in Man. Journal of Hypertension. 3(6). 653–658. 42 indexed citations

17.

Grant, Jonathan, et al.. (1984). Peptide inhibitors of renin.. PubMed. 29(2). 125–6. 7 indexed citations

18.

Szelke, Michael, B Leckie, Anthony Brown, et al.. (1982). H-77: a potent new renin inhibitor. In vitro and in vivo studies.. PubMed. 4(3 Pt 2). 59–69. 37 indexed citations

19.

Szelke, Michael, B Leckie, A. Hallett, et al.. (1982). Potent new inhibitors of human renin. Nature. 299(5883). 555–557. 183 indexed citations

20.

Moore, J. W. & Michael Szelke. (1970). Synthesis of threonine phosphoglycerides. Tetrahedron Letters. 11(50). 4423–4426. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact